Cargando…

Poor tolerance of beta-blockers by elderly patients with heart failure

Despite the well-understood importance of beta-blocker therapy in heart failure, it is sometimes not possible to use beta-blockers in elderly patients due to poor tolerance. In this report, we describe the case of an 83-year-old patient with severe systolic heart failure complicated by aortic valve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yanagisawa, Satoshi, Suzuki, Noriyuki, Tanaka, Toshikazu
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998243/ https://www.ncbi.nlm.nih.gov/pubmed/21152238 http://dx.doi.org/10.2147/CIA.S15158

Ejemplares similares

A case of heart failure complicated with double ventricular response triggered by beta blocker
por: Kazama, Shingo, et al.
Publicado: (2020)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

Increased Risk of Heart Failure in Elderly Patients Treated with Beta-Blockers After AV Node Ablation
por: Bertomeu-Gonzalez, Vicente, et al.
Publicado: (2023)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients
por: Taneva, Borjanka, et al.
Publicado: (2016)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly
por: Ramsay, Emmae N, et al.
Publicado: (2011)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Self-Reported and Actual Beta-Blocker Prescribing for Heart Failure Patients: Physician Predictors
por: Sinha, Sanjai, et al.
Publicado: (2009)

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
por: Kotecha, Dipak, et al.
Publicado: (2013)

Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
por: Perry, Andrew S., et al.
Publicado: (2023)

Different Impact of Beta-Blockers on Long-Term Mortality in Heart Failure Patients with and without Chronic Obstructive Pulmonary Disease
por: Higuchi, Satoshi, et al.
Publicado: (2021)

A Case of Acute Heart Failure due to Immune Checkpoint Blocker Nivolumab
por: Sharma, Munish, et al.
Publicado: (2019)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

Using machine learning to uncover heterogeneity of beta blocker response in heart failure
por: Tison, Geoffrey H.
Publicado: (2022)

The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension
por: Yamaguchi, Satoshi, et al.
Publicado: (2023)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic
por: Chanchai, Rattanachai, et al.
Publicado: (2018)

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2021)

Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry
por: Yazdi, Maryam, et al.
Publicado: (2022)

Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization
por: Allen, Larry A, et al.
Publicado: (2012)

Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance
por: Cohen‐Solal, Alain, et al.
Publicado: (2017)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction
por: Xu, Xizhen, et al.
Publicado: (2019)

Beta Blocker Therapy in Heart Failure Patients with Active Cocaine Use: A Systematic Review
por: Mann, Baldeep K., et al.
Publicado: (2020)

Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure
por: Tamaki, Yodo, et al.
Publicado: (2021)

Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillation
por: XING, Fu-Wei, et al.
Publicado: (2021)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_agb90qrrp5lolnuj9r9lfivpca